NEW YORK – The U.S. authorities advised American travelers property 60 and older not get a chikungunya vaccine arsenic it investigates imaginable broadside effects.
The Centers for Disease Control and Prevention and the Food and Drug Administration posted notices precocious past week connected the vaccine, Valneva’s Ixchiq.
Chikungunya, dispersed by the bites of infected mosquitoes, is simply a debilitating tropical unwellness marked by fever and associated pain. About 100 to 200 cases are reported annually among U.S. travelers.
Last year, the authorities began recommending the vaccine, which is made with weakened chikungunya virus, to U.S. adults who question to countries wherever chikungunya is simply a problem.
But past month, a sheet of vaccine experts who counsel the CDC heard astir an probe into six radical 65 and older — astir of them with different aesculapian problems — who became sick with bosom oregon encephalon symptoms little than a week aft vaccination. More than 10 different akin cases person been reported successful radical from different countries.
European regulators are besides looking into the issue.
The U.S. advisers voted to contented a precaution for radical 65 and older astir getting the vaccine.
They besides recommended that a 2nd chikungunya vaccine — Bavarian Nordic's Vimkunya — beryllium made disposable for radical property 12 and older who are traveling to countries wherever outbreaks of the mosquito-borne unwellness are occurring. CDC officials person not yet announced whether they volition judge those recommendations.
___
The Associated Press Health and Science Department receives enactment from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely liable for each content.
Copyright 2025 The Associated Press. All rights reserved. This worldly whitethorn not beryllium published, broadcast, rewritten oregon redistributed without permission.